MedTrace Logo

The Impact of Portion Plates for Weight Loss on Cardiac Rehabilitation Patients

NCT01054040 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2010-01-22

No results posted yet for this study

Summary

The study will involve cardiac rehabilitation clients and will measure their weight, height, waist circumference and blood pressure comparisons between first and final visit (after 8 weeks). A control group will receive usual care and an experimental group will receive usual care plus a portion control plate for their meals. Patients currently have their waist circumference, weight, height and blood pressure measured at their first visit (week 0) and at their final visit (week 8). This study would compare these three parameters at these same times (week 0 and week 8) between the control and experimental groups. The control group would receive the usual care while the experimental group would receive usual care plus be given a portion control plate at week 0.

The hypothesis of this study is that subjects from the experimental group will have an average reduction in: (a) waist circumference by \> 5%, (b) weight or BMI by \> 5%, and (c) systolic and diastolic blood pressure by \>10%. The subjects in the control group are hypothesized to show an average less than these targets for the experimental group.

Conditions

Interventions

OTHER

Portion plate given to cardiac rehabilitation patients

Patients in the experimental group will be provided with standard care (group and individual nutrition counselling) plus be provided a portion control plate

Sponsors & Collaborators

  • Richmond Health Services

    lead OTHER_GOV

Principal Investigators

  • Monica Redekopp, BSN, PhD · Richmond Health Services

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01054040 on ClinicalTrials.gov